In this study, we employed a combination of immunohistological, biochemical, electrophysiological, pharmacological, and genetic approaches to provide strong experimental evidence for the specific contribution of GABAergic CB1R dysfunction to the cognitive impairments observed in HD. The gene discussed is CNR1; the disease is Huntington disease.